Increase/Decrease in Cash: The total change in cash for the company over the given period.
Genenta Science S.p.A. Unsponsored ADR (GNTA) had Increase/Decrease in Cash of $0.96M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-9.64M |
|
-- |
|
-- |
|
$10.57M |
|
$-10.57M |
|
$0.92M |
|
$-9.64M |
|
$-9.64M |
|
$-9.64M |
|
$-9.64M |
|
$-9.64M |
|
$-9.64M |
|
$-10.57M |
|
$-10.52M |
|
18.27M |
|
18.27M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$15.66M |
|
$0.05M |
|
$0.38M |
|
$16.04M |
|
$2.27M |
|
-- |
|
$0.25M |
|
$2.52M |
|
$13.52M |
|
$13.52M |
|
$13.52M |
|
18.29M |
|
| Cash Flow Statement Financials | |
$-6.75M |
|
$7.45M |
|
$0.29M |
|
$3.99M |
|
$4.96M |
|
|
Increase/Decrease in Cash |
$0.96M |
$0.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-71.32% |
|
-71.32% |
|
-60.12% |
|
-71.32% |
|
$0.74 |
|
$-0.37 |
|
$-0.37 |
|